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Introduction {#sec1}
============

A key goal of life science research is to understand the complex association between biomolecules in various functional systems of a cell, which is important for many biomedical researches, for instance, exploring the pathogenesis of cancer, analyzing genetic diseases, and developing drugs and vaccines. Various molecular components and their interactions play important roles in life activities in cells. For example, proteins are the direct bearers of many fundamental life activities ([@bib55]; [@bib51]; [@bib35]). Most drugs work by binding to a specific protein, altering its biochemical and/or biophysical activities, thereby having multiple effects on multiple functions ([@bib1]). Emerging evidence shows that non-coding RNA (ncRNA), genes that cannot be translated into protein, also play a significant biological role in metabolism, tumorigenesis, and cellular development ([@bib21]; [@bib50]; [@bib4]), including microRNAs, long ncRNAs, and circular RNAs. Microbes, as environment or co-evolved partner, also have critical impacts on human\'s health and disease ([@bib16]; [@bib34]; [@bib27]). These molecules and their synergistic interactions maintain the special cellular activities, operating as part of a highly interconnected molecular association network.

Owing to the rapid development of related molecular biology, computational biology, and omics research, many valuable researches on individual intermolecular associations in human were developed and a variety of valuable experimental data have been released, e.g., mRNA-protein interactions ([@bib36]; [@bib39]), long non-coding RNA (lncRNA)-protein interactions ([@bib50]), protein-protein interactions ([@bib53]), micro RNA (miRNA)-protein interactions ([@bib18]), and miRNA-lncRNA interactions ([@bib24], [@bib25]). Considering exogenous chemical compound or complex disease, there are drug-disease interactions ([@bib45]; [@bib17]; [@bib57]), miRNA-disease associations ([@bib52]; [@bib46]), drug-protein interactions ([@bib8]; [@bib31]), protein-disease associations ([@bib29]; [@bib45]), and lncRNA-disease associations ([@bib9]). Emerging research on circular RNA (circRNA) shows there are also circRNA-miRNA associations ([@bib56]), circRNA-protein interactions ([@bib11]), and circRNA-disease associations ([@bib58]). The microbes and drugs also have been involved into many biological systems ([@bib34]; [@bib42]).

These researches focus on individual associations between two molecules, and there are several studies that have considered the association between multiple biomolecules; e.g., Davis et al. manually compiled interactions among chemical, gene, and disease from publications to construct a chemical-gene-disease network ([@bib14]). Liu et al. connected the associations between miRNA, target gene, lncRNA, and disease to build a network for calculating the similarity of miRNA and disease to predict miRNA-disease associations ([@bib33]). The concerns of these studies are on two or very limited intermolecular relationships. However, intermolecular interactions are widespread and interconnected.

Inspired by this systematic perspective, to address some limitations of existing studies, we propose a molecular association network (MAN)-based framework to predict molecule-molecule associations by learning behavior and attribute feature of biomolecules, named MMI-Pred. The workflow of MMI-Pred is shown in [Figure 1](#fig1){ref-type="fig"}. First, a comprehensive MAN network is generated by connecting extensive associations between miRNAs, lncRNAs, circular RNAs, mRNAs, proteins, drugs, microbes, and diseases. It contains 14,315 molecular nodes and 18 kinds of, 114,150 association entries. Then, a random walk and skip-gram algorithm-based network embedding model node2vec is adopted to learn the behavioral features of biomolecular nodes. And the attribute feature is also calculated from sequence, structure, and phenotype information of different biomolecules. Moreover, both the attribute and behavior features are combined to train a Random Forest classifier ([@bib7]) to predict intermolecular associations. To evaluate the performance of MMI-Pred, the predictive ability of the entire MAN is first evaluated under 5-fold cross-validation. Furthermore, MMI-Pred was applied to predict miRNAs most relevant to Breast Neoplasms and Colon Neoplasms as a case study. Experimental results demonstrate that this work brings new insights and a promising prediction method for discovering and understanding intermolecular associations.Figure 1The Workflow of the MMI-PredThe molecular association network is formed by connecting multitype intermolecular associations among mRNAs, proteins, miRNAs, lncRNAs, circRNAs, drugs, microbes, and diseases. Both the handcrafted attribute features and behavior features learned by network embedding method of biomolecules are jointly fed into a random forest classifier for training to predict potential intermolecular interactions.

Results {#sec2}
=======

Molecular Association Network {#sec2.1}
-----------------------------

The extensive associations between mRNAs, proteins, miRNAs, drugs, lncRNAs, circRNAs, microbes, and diseases are interconnected and form a complex molecular association network. Considering that same biomolecule may have different naming in different databases, we used the same naming convention to unify the naming of the eight molecules (nodes), e.g., STRING ID for protein ([@bib43]), miRBase ID for miRNA ([@bib28]), NONCODE ID for lncRNA ([@bib20]), circBase ID for circRNA ([@bib22]), DrugBank ID for drug ([@bib47]), and NIH MeSH ID for microbe and disease. Then, the duplicate and completely isolated associations are removed. Finally, there are 14,315 molecule nodes and 114,150 association links in the MAN. The distribution of molecules nodes and association types is shown in [Figure 2](#fig2){ref-type="fig"}. The MAN obtained 39,674 protein-protein interactions from STRING v11 ([@bib43]); 421 circRNA-disease associations (links) from Circ2Disease ([@bib49]), CircRNA disease ([@bib58]), LncRNADisease 2.0 ([@bib3]), and CircR2Disease ([@bib19]); 1,378 circRNA-miRNA associations from SomamiR 2.0 ([@bib5]); 3,416 mRNA-disease associations from DisGeNET ([@bib40]); 175 microbe-disease associations from HMDAD ([@bib34]); 17,414 drug-disease interactions from CTD ([@bib15]); 3,915 drug-mRNA associations from PharmGKB ([@bib23]); 8 drug-microbe associations from PharmacoMicrobiomics ([@bib41]); 11,396 drug-protein interactions from DrugBank ([@bib47]); 874 lncRNA-disease associations from LncRNADisease ([@bib10]) and lncRNASNP2 ([@bib37]); 525 lncRNA-mRNA interactions from LncRNA2Target ([@bib12]); 8,634 lncRNA-miRNA interactions from lncRNASNP2 ([@bib37]); 5,115 lncRNA-protein interactions from NPInter v2.0 ([@bib54]); 10,696 miRNA-disease associations from HMDD ([@bib30]); 3,012 mRNA-protein associations from NCBI data; 269 miRNA-drug associations from SM2miR ([@bib32]); 5,186 miRNA-mRNA associations from MiRTarBase ([@bib13]); and 2,042 miRNA-protein interactions from NPInter v2.0 ([@bib54]) and TransmiR v2.0 ([@bib44]).Figure 2The Number and Type Distribution of Biomolecule Nodes and Intermolecular Associations in the Molecular Association Network

Predictive Performance Evaluation of MMI-Pred {#sec2.2}
---------------------------------------------

The overall performance of MMI-Pred for predicting potential associations between arbitrary molecules in the MAN network was first evaluated under 5-fold cross-validation. In each fold validation, only the associations in the train set can be used to exploit the latent high-level representation of biomolecules nodes by network embedding model, which can avoid label leakage. As many studies have confirmed, there is a bias in measuring the performance of machine learning models using only precision or recall rates. When evaluating the classification performance of a model, the precision-recall curve and area under the precision-recall curve (AUPR) values that balance these two metrics are adopted. The overall performance of MMI-Pred is shown in [Figure 3](#fig3){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}.Figure 3The Performance of MMI-Pred on Entire MAN Dataset under 5-Fold Cross-ValidationOn the left is the ROC curve and AUC value, and on the right is the precision-recall curve and AUPR value.Table 1The 5-Fold Cross-Validation Performance of MMI-Pred on MAN DatasetFoldAcc. (%)Sen. (%)Spec. (%)Prec. (%)MCC (%)AUC (%)093.4291.6495.295.0286.997.81193.5191.6095.4395.2587.0997.84293.4892.0894.8794.7286.9997.72393.4391.6295.2495.0686.9197.76493.6491.8295.4795.387.3597.86Average93.50 ± 0.0991.75 ± 0.2095.24 ± 0.2495.07 ± 0.2387.05 ± 0.1997.80 ± 0.06

As [Figure 3](#fig3){ref-type="fig"} shows, in each fold cross-validation, the performance of MMI-Pred is very closed, which means the robust of our model. In whole MAN network, the model obtained a remarkable performance with high accuracy of 93.50% and high area under the curve (AUC) value of 0.9780. And the sensitivity, specificity, and precision of the model are 91.75%, 95.24%, 95.07%, respectively. The MMI-Pred receives a high AUPR value of 0.9707. In the case of class imbalance in classification tasks, accuracy is meaningless, for example, suppose there are 90 negative samples and 10 positive samples in a dataset, even if the model directly classified all samples into negative samples, the accuracy even is 90%, but this is obviously meaningless. And when the thresholds are different, the outputs are different. So, receiver operating characteristic (ROC) curve that can avoid these problems was used to measure our model\'s performance. The standard deviation (SD) of each performance value is 0.09%, 0.20%, 0.24%, 0.23%, 0.19%, and 0.06%, respectively, which can show the stable and robust of MMI-Pred in predicting any molecule-molecule associations in the MAN.

Evaluate the Impact of Network Behavior and Attribute Feature {#sec2.3}
-------------------------------------------------------------

Molecules in the association network are similar to people in social networks, and they have both attributes and network behavior features. Both the network behavior and attribute features are adopted as representations of biomolecules. For mRNA, miRNA, lncRNA, circRNA, and protein, their attributes are nucleic acid or amino acid sequence. The k-mer is used to transfer sequences into numerical vector. For disease and microbe, their direct attribute is hard to gain, their phenotypes are employed to calculate their semantic similarity as attribute feature. The fingerprints of drug compounds that stand for the chemical structure are used as their attribute. All nodes in the MAN network can be calculated for their network embedding based on their behavior with other nodes in the network. We tested them under the same experimental conditions to verify the performance of these features and their impact on the predicted results.

As [Figure 4](#fig4){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"} show, the MMI-Pred model can achieve high accuracy more than 90% whether using attribute features or behavior features, which indicate that the distinguishing power of features is acceptable. In general, the performance of behavior feature is a bit better than the attribute features, whereas the best performance is obtained when using both two features. In addition, when the nodes or network behavior attributes of some new molecules are missing, the combination of these two features can enhance the robustness of the model and ensure that the prediction can be performed normally.Figure 4The Comparison of Network Behavior and Attribute Features Using Random Forest ClassifierOn the left is the ROC curve and AUC value, and on the right is the PR curve and AUPR value.Table 2Comparison of Attribute and Behavior Features Using Random Forest Classifier under 5-Fold Cross-ValidationFeatureAcc. (%)Sen. (%)Spec. (%)Prec. (%)MCC (%)AUC (%)Attribute90.69 ± 0.1489.49 ± 0.1991.89 ± 0.1591.69 ± 0.1581.40 ± 0.2795.85 ± 0.12Behavior91.64 ± 0.1888.44 ± 0.1594.83 ± 0.2194.48 ± 0.2383.45 ± 0.3696.87 ± 0.17Combined93.50 ± 0.0991.75 ± 0.2095.24 ± 0.2495.07 ± 0.2387.05 ± 0.1997.80 ± 0.06

Compared with Widely Used Machine Learning Classifiers {#sec2.4}
------------------------------------------------------

To verify the impact of different machine learning models on performance, in this section, we compared the performance of the Logistic Regression (LR), AdaBoost, Naive Bayes (NB), XGBoost, and Random Forest as classifier of our framework using the attribute and behavior feature under the same experimental conditions. The Random Forest classifier and other contrast classifiers are implemented by Scikit-learn ([@bib38]) and use only default parameters.

As shown in [Figure 5](#fig5){ref-type="fig"} and [Table 3](#tbl3){ref-type="table"}, the proposed method MMI-Pred that uses Random Forest classifier achieves the best performance. LR is a commonly used binary classification algorithm that directly models the possibility of classification without the assumption of data distribution in advance. AdaBoost is the most famous representative of the Boosting algorithm. It requires the base classifier to learn specific data distributions, which can be achieved by re-weighting. The NB classifier is a series of simple probability classifiers based on Bayesian theorem based on independence between hypothetical features. XGBoost is an improvement of the Gradient Boosting Decision Tree (GBDT) implementation. Random Forest is an efficient, fast, and easy-to-use decision tree-based algorithm, which was proved to be the most effective model in this task by rigorous experimental results.Figure 5The Performance Comparison between MMI-Pred and Four Different Comparison Models Include Naive Bayes, Adaboost, Logistic Regression, and XGBoost ClassifiersTable 3The Performance Comparison of Different Machine Learning ClassifiersMethodAcc. (%)Sen. (%)Spec. (%)Prec. (%)MCC (%)AUCNB59.6431.3587.9472.223.3875.57LR80.6182.4478.7979.5461.2787.21AdaBoost80.9182.6879.1479.8661.8688.5XGBoost85.6778.6692.6891.4872.0594.44Proposed method93.5091.7595.2495.0787.0597.80

Case Study: Predicting *Human* Disease-Associated miRNAs {#sec2.5}
--------------------------------------------------------

To demonstrate the predictive ability of the proposed model on specific types of interactions, the MMI-Pred was executed to predict the miRNAs that are most relevant to two diseases, including Breast neoplasms and Colon neoplasms, as case studies. In the MAN, all miRNA-disease associations are from the HMDD database. When conducting case studies for individual disease, we trained the MMI-Pred predictor with a MAN network that removed those miRNA-Breast neoplasms (or Colon neoplasms) association pairs that overlapped with the dbDEMC 2.0 database ([@bib48]). Then, the trained model performs prediction on testing Breast neoplasms or Colon neoplasms-miRNAs pairs. This processing can also be considered as cross-dataset validation. In the context of screening for disease-associated miRNAs, the candidate rankings are more valuable than the report of the overall false-positive, false-negative, and other indicators of the framework. Therefore, when the MMI-Pred is executed on the test samples, we rank the possible associated miRNAs based on the probability values output by the MMI-Pred. And then, the top 30 high-scored miRNAs for each disease are validated through the dbDEMC database.

Breast cancer is the most terrible killer of women\'s health. In 2018, about 2.1 million new cases of Breast tumor in women were diagnosed globally. And breast cancer accounts for about a quarter of the globally diagnosed cases of female cancer ([@bib6]). Among the world\'s latest cancer incidence rates, female breast cancer also ranks second, accounting for 11.6% of the total cancer population. Studies have shown that miRNAs have the most significant expression difference between normal and cancer tissues, which can be used as tumor markers ([@bib26]). As shown in [Table 4](#tbl4){ref-type="table"}, the top 30 highest ranked breast cancer-associated miRNAs are predicted by MMI-Pred, and 25 of them were confirmed.Table 4The Top 30 miRNAs Relevant to Breast Cancer Predicted by MMI-PredmiRNAdbDEMCmiRNAdbDEMChsa-mir-186-5pConfirmedhsa-mir-539-5pConfirmedhsa-mir-216a-5pUnconfirmedhsa-mir-330-5pConfirmedhsa-mir-154-5pConfirmedhsa-mir-543Confirmedhsa-mir-181d-5pConfirmedhsa-mir-4262Unconfirmedhsa-mir-449bConfirmedhsa-mir-384Confirmedhsa-mir-211-5pConfirmedhsa-mir-4458Confirmedhsa-mir-504-5pUnconfirmedhsa-mir-28-5pConfirmedhsa-mir-1271-5pConfirmedhsa-mir-136-5pConfirmedhsa-mir-300Confirmedhsa-mir-99b-5pConfirmedhsa-mir-337-5pConfirmedhsa-mir-518-5pUnconfirmedhsa-mir-637Confirmedhsa-mir-217Confirmedhsa-mir-517a-3pConfirmedhsa-mir-664Confirmedhsa-mir-671-5pConfirmedhsa-mir-508-5pConfirmedhsa-mir-525-5pUnconfirmedhsa-mir-431-5pConfirmedhsa-mir-532-5pConfirmedhsa-mir-483-5pConfirmed

Colon cancer ranks fourth in overall cancer incidence, accounting for 6.1%, but ranks second in mortality, accounting for 9.2% ([@bib6]). And recent research confirms that miRNAs play a role in carcinogenesis through DNA methylation and histone modifications and *human* colorectal tumorigenesis ([@bib2]). The predicted top 30 miRNAs with the highest score that associated with Colon Neoplasms are shown in [Table 5](#tbl5){ref-type="table"}; among them, 26 of miRNA-disease associations were confirmed.Table 5The Top 30 miRNAs Relevant to Colon Cancer Predicted by MMI-PredmiRNAdbDEMCmiRNAdbDEMChsa-mir-186-5pConfirmedhsa-mir-16-5pConfirmedhsa-mir-485-5pConfirmedhsa-mir-497-5pConfirmedhsa-mir-206Confirmedhsa-mir-33b-5pConfirmedhsa-mir-19b-3pConfirmedhsa-mir-7-5pUnconfirmedhsa-mir-361-5pConfirmedhsa-mir-185-5pConfirmedhsa-mir-154-5pConfirmedhsa-mir-26b-5pConfirmedhsa-mir-9-5pUnconfirmedhsa-mir-34c-5pConfirmedhsa-mir-122-5pConfirmedhsa-mir-449b-5pConfirmedhsa-mir-590-5pConfirmedhsa-mir-139-5pConfirmedhsa-mir-340-5pConfirmedhsa-mir-134-5pUnconfirmedhsa-mir-211-5pConfirmedhsa-mir-153-3pUnconfirmedhsa-mir-149-5pConfirmedhsa-mir-449a-5pConfirmedhsa-mir-183-5pConfirmedhsa-mir-129-5pConfirmedhsa-mir-503-5pConfirmedhsa-mir-136-5pConfirmedhsa-mir-324-5pConfirmedhsa-mir-10a-5pConfirmed

Discussion {#sec3}
==========

In this research, we proposed a computational framework based on network representation learning to predict any associations between molecules. First, the molecular association network is constructed by integrating 18 types of associations, 14,315 nodes, 114,150 molecular associations between mRNA, lncRNA, protein, miRNA, circRNA, drug, disease, and microbe. The performance of the framework is evaluated on the entire network under 5-fold cross-validation. To demonstrate the predictive ability, we use MMI-Pred to predict miRNAs most relevant to Breast cancer and Colon cancer as case studies. Experimental results proved that the MMI-Pred can predict any potential associations between molecules. Moreover, network embedding representations obtained based on MAN network and network representation learning algorithms can serve as efficient low-rank representations of disease, microbes, and other biological components whose features are difficult to be extracted by computational algorithms. In addition, randomly sampled unknown samples without known association are used as negative samples in this work; high-quality negative samples or sampling techniques are worth studying. It is anticipated that this work can help to advance related intermolecular associations research in a long term.

Limitations of the Study {#sec3.1}
------------------------

In this study, we provide a systematic and holistic perspective on intermolecular interactions and provide a machine learning method to model molecular properties and intermolecular behaviors in order to promote understanding and discover new intermolecular interactions. This work still has some limitations that deserve attention and further study. First, the interactions screened from public databases for building molecular association networks are not complete, although to our best knowledge, these databases are already of high quality and relatively comprehensive. For nodes that do not exist in the network, the network embedding feature will be not applicable. More complete data will be more conducive to comprehensive modeling of the relationship between biomolecules. Second, the MAN network is a heterogeneous information network that contains many types of molecules and many different association relationships. When characterizing the network behavior of biomolecule nodes, the network embedding algorithm does not use the heterogeneous information. The further study of network representation learning algorithms for heterogeneous information networks will be very helpful.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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